In-Principle Approval
Name of Company*	Neogen Chemicals Limited
ISIN*	INE136S01016
Corporate Identity Number (CIN) of the Listed Entity*	L24200MH1989PLC050919
Permanent Account Number (PAN)*	AAACN5836E
BSE Scrip code*	542665
NSE Symbol	NEOGEN
MSEI Symbol	NA
Board resolution approving the issue of specified securities *	05-10-2023
Object of the Issue (As per Notice/offer document) *
Category of Allottee*	Non Promoter
Detials of security
Security Type	Number of securities	Amount to be raised ( Rs in Lakhs)	Relavent Date			Minimum Issue Price (per security)	Terms of Payment in % (100/25/other specify)
Security Type	Number of securities	Amount to be raised ( Rs in Lakhs)	DD	MM	YYYY	Minimum Issue Price (per security)	Terms of Payment in % (100/25/other specify)
Equity Shares	1442358	25299.96	28	09	2023	1754.07	100




Total amount to be raised ( Rs in Lakhs)		25299.96
Consideration*	Cash
Description of other consideration
Details of allottes*
Date Of Submission	17-10-2023
Notes

Details of allottes
Sr.	Name of allottes	Security type	No of securities to be allotted
1	SBI Large and Midcap Fund	Equity Shares	285051
2	SBI Contra Fund	Equity Shares	222340
3	SBI Equity Savings Fund	Equity Shares	62711
4	Quant Small Cap Fund	Equity Shares	427577
5	TATA India Tax Saving Fund	Equity Shares	199536
6	India Acorn Fund Limited	Equity Shares	85515
7	Ashoka India Equity Investment Trust PLC	Equity Shares	57010
8	Invesco India Small Cap Fund	Equity Shares	57010
9	Alchemy Long term Ventures Fund	Equity Shares	45608

Object of the Issue
Sr.	Object	Details of the object
1	Investment in wholly owned subsidiaries of the Company viz. Neogen Ionics Limited and BuLi Chemicals India Private Limited	Amount: Rs. 100 Crores Utilisation timeline: 1 - 12 months There may be variation not exceeding +/- 10% in the estimated amounts specified against each of the objects.
2	Meeting Working Capital Requirements	Amount: Rs. 91 Crores Utilisation timeline: 1 - 6 months There may be variation not exceeding +/- 10% in the estimated amounts specified against each of the objects.
3	General Corporate Purposes	Amount: Rs. 62 Crores Utilisation timeline: 1 - 12 months *The amount utilized for general corporate purpose shall not exceed 25% of the Gross Proceeds There may be variation not exceeding +/- 10% in the estimated amounts specified against each of the objects. The above stated fund requirements are based on internal management estimates and have not been appraised by any bank, financial institution or any other external agency. They are based on current circumstances of our business. The Company may have to revise its estimates from time to time on account of various factors beyond its control, such as financial, market and sectoral conditions, competitive environment, business performance and strategy and interest or exchange rate fluctuations. Consequently, the funding requirements of our Company and deployment schedules are subject to revision in the future at the discretion of the management. Pending utilization of the proceeds from the Preferential Issue, the Company shall invest such proceeds in money market instruments including money market mutual funds, deposits in scheduled commercial banks or any other investment as permitted under applicable laws.